Estrogen and tamoxifen reverse manganese-induced glutamate transporter impairment in astrocytes

Journal of Neurochemistry

Volumn 110, Issue 2, 2009, Pages 530-544

  Lee, Eun Sook Y ^a   Sidoryk, Marta ^b   Jiang, Haiyan ^b   Yin, Zhaobao ^b   Aschner, Michael ^b  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

17 estradiol; Astrocytes; Astroglial glutamate transporters; Glutamate transporters; Tamoxifen; Transforming growth factor 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 HYDROXYASPARTIC ACID; CELL SURFACE PROTEIN; COMPLEMENTARY DNA; DIHYDROKAINIC ACID; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; MANGANESE; MESSENGER RNA; METHIONINE SULFOXIMINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; BIOTINYLATION; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY; DEGENERATIVE DISEASE; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LONG TERM EXPOSURE; MANGANISM; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS; MANGANESE; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN;

EID: 67649552763     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06105.x     Document Type: Article

References (58)

1. Abe K. Saito H. (2001) Possible linkage between glutamate transporter and mitogen-activated protein kinase cascade in cultured rat cortical astrocytes. J. Neurochem. 76, 217 223. (Pubitemid 32044385)
2. Aschner M., Gannon M. Kimelberg H. K. (1992) Manganese uptake and efflux in cultured rat astrocytes. J. Neurochem. 58, 730 735.
3. Aschner M., Vrana K. E. Zheng W. (1999) Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 20, 173 180. (Pubitemid 29268562)
4. Azcoitia I., Garcia-Ovejero D., Chowen J. A. Garcia-Segura L. M. (2001) Astroglia play a key role in the neuroprotective actions of estrogen. Prog. Brain Res. 132, 469 478.
5. Barbeau A. (1984) Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). Neurotoxicology 5, 13 35.
6. Brouillet E. P., Shinobu L., McGarvey U., Hochberg F. Beal M. F. (1993) Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp. Neurol. 120, 89 94. (Pubitemid 23114032)
7. Buisson A., Nicole O., Docagne F., Sartelet H., Mackenzie E. T. Vivien D. (1998) Up-regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor beta1. FASEB J. 12, 1683 1691. (Pubitemid 28553663)
8. Buisson A., Lesne S., Docagne F., Ali C., Nicole O., MacKenzie E. T. Vivien D. (2003) Transforming growth factor-beta and ischemic brain injury. Cell. Mol. Neurobiol. 23, 539 550. (Pubitemid 37071483)
9. Cotzias G. C., Horiuchi K., Fuenzalida S. Mena I. (1968) Chronic manganese poisoning. Clearance of tissue manganese concentrations with persistance of the neurological picture. Neurology 18, 376 382.
10. Danbolt N. C. (2001) Glutamate uptake. Prog. Neurobiol. 65, 1 105. (Pubitemid 32479155)
11. Dhandapani K. M. Brann D. W. (2002) Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol. Reprod. 67, 1379 1385. (Pubitemid 35204912)
12. Dhandapani K. Brann D. (2003a) Neuroprotective effects of estrogen and tamoxifen in vitro: a facilitative role for glia? Endocr. 21, 59 66. (Pubitemid 36677344)
13. Dhandapani K. M. Brann D. W. (2003b) Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia. Cell Biochem. Biophys. 39, 13 22. (Pubitemid 41270804)
14. Dhandapani K. M. Brann D. W. (2007) Role of astrocytes in estrogen-mediated neuroprotection. Exp. Gerontol. 42, 70 75. (Pubitemid 44937829)
15. Dhandapani K. M., Wade F. M., Mahesh V. B. Brann D. W. (2005) Astrocyte-derived transforming growth factor-[beta] mediates the neuroprotective effects of 17[beta]-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology 146, 2749 2759. (Pubitemid 40695579)
16. Dunlop J. (2006) Glutamate-based therapeutic approaches: targeting the glutamate transport system. Curr. Opin. Pharmacol. 6, 103 107. (Pubitemid 43103826)
17. Dunlop J. Butera J. A. (2006) Ligands targeting the excitatory amino acid transporters (EAATs). Curr. Top. Med. Chem. 6, 1897 1906. (Pubitemid 44383205)
18. Erikson K. Aschner M. (2002) Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology 23, 595 602. (Pubitemid 36527679)
19. Erikson K. M., Suber R. L. Aschner M. (2002) Glutamate/aspartate transporter (GLAST), taurine transporter and metallothionein mRNA levels are differentially altered in astrocytes exposed to manganese chloride, manganese phosphate or manganese sulfate. Neurotoxicology 23, 281 288.
20. Ferrarese C., Zoia C., Pecora N. et al. (1999) Reduced platelet glutamate uptake in Parkinson's disease. J. Neural. Transm. 106, 685 692. (Pubitemid 29401356)
21. Figiel M., Maucher T., Rozyczka J., Bayatti N. Engele J. (2003) Regulation of glial glutamate transporter expression by growth factors. Exp. Neurol. 183, 124 135. (Pubitemid 37075863)
22. Gegelashvili G. Schousboe A. (1997) High affinity glutamate transporters: regulation of expression and activity. Mol. Pharmacol. 52, 6 15. (Pubitemid 27318612)
23. Gillessen T., Budd S. L. Lipton S. A. (2002) Excitatory amino acid neurotoxicity. Adv. Exp. Med. Biol. 513, 3 40. (Pubitemid 36332402)
24. Hazell A. S. (2002) Astrocytes and manganese neurotoxicity. Neurochem. Int. 41, 271 277. (Pubitemid 34775001)
25. Hazell A. S. Norenberg M. D. (1997) Manganese decreases glutamate uptake in cultured astrocytes. Neurochem. Res. 22, 1443 1447. (Pubitemid 27461119)
26. Kimelberg H. K., Feustel P. J., Jin Y., Paquette J., Boulos A., Keller R. W. Jr. Tranmer B. I. (2000) Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion. Neuroreport 11, 2675 2679. (Pubitemid 30672444)
27. Koeberle P. D. Bahr M. (2008) The upregulation of GLAST-1 is an indirect antiapoptotic mechanism of GDNF and neurturin in the adult CNS. Cell Death Differ. 15, 471 483. (Pubitemid 351267298)
28. Kondo K., Hashimoto H., Kitanaka J., Sawada M., Suzumura A., Marunouchi T. Baba A. (1995) Expression of glutamate transporters in cultured glial cells. Neurosci. Lett. 188, 140 142.
29. Leof E. B. (2000) Growth factor receptor signalling: location, location, location. Trends Cell Biol. 10, 343 348. (Pubitemid 30445242)
30. Liang Z., Valla J., Sefidvash-Hockley S., Rogers J. Li R. (2002) Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J. Neurochem. 80, 807 814. (Pubitemid 34809233)
31. Liao S. L., Ou Y. C., Chen S. Y., Chiang A. N. Chen C. J. (2007) Induction of cyclooxygenase-2 expression by manganese in cultured astrocytes. Neurochem. Int. 50, 905 915.
32. Masliah E., Alford M., DeTeresa R., Mallory M. Hansen L. (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40, 759 766. (Pubitemid 26415188)
33. Moosmann B. Behl C. (1999) The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl Acad. Sci. USA, 96, 8867 8872. (Pubitemid 29374674)
34. Mutkus L., Aschner J. L., Syversen T., Shanker G., Sonnewald U. Aschner M. (2005) In vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells is inhibited by the ethylmercury-containing preservative thimerosal. Biol. Trace Elem. Res. 105, 71 86. (Pubitemid 41009049)
35. Normandin L. Hazell A. S. (2002) Manganese neurotoxicity: an update of pathophysiologic mechanisms. Metab. Brain Dis. 17, 375 387. (Pubitemid 36204767)
36. O'Neill K., Chen S. Brinton R. D. (2004a) Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Exp. Neurol. 185, 63 80. (Pubitemid 38010279)
37. O'Neill K., Chen S. Diaz Brinton R. (2004b) Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease. Exp. Neurol. 188, 268 278. (Pubitemid 38891587)
38. Pawlak J., Brito V., Kuppers E. Beyer C. (2005) Regulation of glutamate transporter GLAST and GLT-1 expression in astrocytes by estrogen. Brain Res. Mol. Brain Res. 138, 1 7. (Pubitemid 41032924)
39. Peterson R. S., Lee D. W., Fernando G. Schlinger B. A. (2004) Radial glia express aromatase in the injured zebra finch brain. J. Comp. Neurol. 475, 261 269. (Pubitemid 38850023)
40. Plaitakis A. Shashidharan P. (2000) Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J. Neurol. 247 (Suppl 2 II25 II35.
41. Robinson M. B. (2002) Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J. Neurochem. 80, 1 11. (Pubitemid 34614572)
42. Rothstein J. D., Martin L. J. Kuncl R. W. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 326, 1464 1468.
43. Rothstein J. D., Dykes-Hoberg M., Pardo C. A. et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675 686. (Pubitemid 26103145)
44. Rothstein J. D., Patel S., Regan M. R. et al. (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73 77. (Pubitemid 40101145)
45. Sheldon A. L. Robinson M. B. (2007) The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 51, 333 355. (Pubitemid 47503456)
46. Shi J., Zhang Y. Q. Simpkins J. W. (1997) Effects of 17beta-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats. Exp. Brain Res. 117, 200 206. (Pubitemid 27488781)
47. Simpkins J. W., Green P. S., Gridley K. E., Singh M., de Fiebre N. C. Rajakumar G. (1997) Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am. J. Med. 103, 19S 25S. (Pubitemid 27444161)
48. Sloot W. N., van der Sluijs-Gelling A. J. Gramsbergen J. B. (1994) Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus. J. Neurochem. 62, 205 216.
49. Sortino M. A., Chisari M., Merlo S., Vancheri C., Caruso M., Nicoletti F., Canonico P. L. Copani A. (2004) Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology 145, 5080 5086. (Pubitemid 39551128)
50. Spadoni F., Stefani A., Morello M., Lavaroni F., Giacomini P. Sancesario G. (2000) Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp. Brain Res. 135, 544 551.
51. Suzuki Y., Mouri T., Nishiyama K. Fujii N. (1975) Study of subacute toxicity of manganese dioxide in monkeys. Tokushima J. Exp. Med. 22, 5 10.
52. Suzuki K., Ikegaya Y., Matsuura S., Kanai Y., Endou H. Matsuki N. (2001) Transient upregulation of the glial glutamate transporter GLAST in response to fibroblast growth factor, insulin-like growth factor and epidermal growth factor in cultured astrocytes. J. Cell Sci. 114, 3717 3725. (Pubitemid 33041053)
53. Tao F., Lu S. D., Zhang L. M., Huang Y. L. Sun F. Y. (2001) Role of excitatory amino acid transporter 1 in neonatal rat neuronal damage induced by hypoxia-ischemia. Neuroscience 102, 503 513. (Pubitemid 32171872)
54. Vivien D. Ali C. (2006) Transforming growth factor-beta signalling in brain disorders. Cytokine Growth Factor Rev. 17, 121 128. (Pubitemid 43117521)
55. Wang X., Dykens J. A., Perez E., Liu R., Yang S., Covey D. F. Simpkins J. W. (2006) Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 70, 395 404. (Pubitemid 43920829)
56. Wyss-Coray T. (2004) Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration. J. Mol. Neurosci. 24, 149 153. (Pubitemid 41359181)
57. Zhao L., Chen S., Ming Wang J. Brinton R. D. (2005) 17beta-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism. Neuroscience 132, 299 311. (Pubitemid 40417905)
58. Zhu Y., Yang G. Y., Ahlemeyer B., Pang L., Che X. M., Culmsee C., Klumpp S. Krieglstein J. (2002) Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 22, 3898 3909. (Pubitemid 37465698)